English
简体中文
Total: £ 56.28
Published Date: 2026-02-05 | Pages: 111 | Tables: 113 | Medical Care
The global Nuclear Medicine market was valued at US$ 7224 million in 2025 and is anticipated to reach US$ 11830 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
This report delivers a comprehensive overview of the global Nuclear Medicine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nuclear Medicine. The Nuclear Medicine market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nuclear Medicine market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nuclear Medicine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Segment by Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Segment by Application
Oncology
Thyroid
Cardiology
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Nuclear Medicine companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2021–2032)
2.2 Global Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Nuclear Medicine Historic Market Size by Region (2021–2026)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2027–2032)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2021–2026)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2021–2026)
3.2 Global Top Nuclear Medicine Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2025
3.5 Global Key Players of Nuclear Medicine Head Offices and Areas Served
3.6 Global Key Players of Nuclear Medicine, Products and Applications
3.7 Global Key Players of Nuclear Medicine, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2021–2026)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2027–2032)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2021–2026)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Nuclear Medicine Market Size (2021–2032)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Nuclear Medicine Market Size by Country (2021–2026)
6.4 North America Nuclear Medicine Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2021–2032)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Nuclear Medicine Market Size by Country (2021–2026)
7.4 Europe Nuclear Medicine Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2021–2032)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2021–2026)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2021–2032)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Nuclear Medicine Market Size by Country (2021–2026)
9.4 Latin America Nuclear Medicine Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2021–2032)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2021–2026)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Nuclear Medicine Introduction
11.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2021–2026)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nuclear Medicine Introduction
11.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2021–2026)
11.2.5 GE Healthcare Recent Development
11.3 Jubilant Pharma
11.3.1 Jubilant Pharma Company Details
11.3.2 Jubilant Pharma Business Overview
11.3.3 Jubilant Pharma Nuclear Medicine Introduction
11.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2021–2026)
11.3.5 Jubilant Pharma Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Nuclear Medicine Introduction
11.4.4 Novartis Revenue in Nuclear Medicine Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 Curium Pharma
11.5.1 Curium Pharma Company Details
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma Nuclear Medicine Introduction
11.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2021–2026)
11.5.5 Curium Pharma Recent Development
11.6 SIEMENS
11.6.1 SIEMENS Company Details
11.6.2 SIEMENS Business Overview
11.6.3 SIEMENS Nuclear Medicine Introduction
11.6.4 SIEMENS Revenue in Nuclear Medicine Business (2021–2026)
11.6.5 SIEMENS Recent Development
11.7 Lantheus
11.7.1 Lantheus Company Details
11.7.2 Lantheus Business Overview
11.7.3 Lantheus Nuclear Medicine Introduction
11.7.4 Lantheus Revenue in Nuclear Medicine Business (2021–2026)
11.7.5 Lantheus Recent Development
11.8 Bracco Imaging
11.8.1 Bracco Imaging Company Details
11.8.2 Bracco Imaging Business Overview
11.8.3 Bracco Imaging Nuclear Medicine Introduction
11.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2021–2026)
11.8.5 Bracco Imaging Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Nuclear Medicine Introduction
11.9.4 Bayer Revenue in Nuclear Medicine Business (2021–2026)
11.9.5 Bayer Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Nuclear Medicine Introduction
11.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2021–2026)
11.10.5 Eli Lilly Recent Development
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Details
11.11.2 Aurobindo Pharma Business Overview
11.11.3 Aurobindo Pharma Nuclear Medicine Introduction
11.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2021–2026)
11.11.5 Aurobindo Pharma Recent Development
11.12 Mundipharma
11.12.1 Mundipharma Company Details
11.12.2 Mundipharma Business Overview
11.12.3 Mundipharma Nuclear Medicine Introduction
11.12.4 Mundipharma Revenue in Nuclear Medicine Business (2021–2026)
11.12.5 Mundipharma Recent Development
11.13 China Isotope & Radiation
11.13.1 China Isotope & Radiation Company Details
11.13.2 China Isotope & Radiation Business Overview
11.13.3 China Isotope & Radiation Nuclear Medicine Introduction
11.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2021–2026)
11.13.5 China Isotope & Radiation Recent Development
11.14 Yantai Dongcheng
11.14.1 Yantai Dongcheng Company Details
11.14.2 Yantai Dongcheng Business Overview
11.14.3 Yantai Dongcheng Nuclear Medicine Introduction
11.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2021–2026)
11.14.5 Yantai Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Diagnostic Nuclear Medicine
Table 3. Key Players of Therapeutic Nuclear Medicine
Table 4. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Nuclear Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Nuclear Medicine Market Size by Region (US$ Million), 2021–2026
Table 7. Global Nuclear Medicine Market Share by Region (2021–2026)
Table 8. Global Nuclear Medicine Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Nuclear Medicine Market Share by Region (2027–2032)
Table 10. Nuclear Medicine Market Trends
Table 11. Nuclear Medicine Market Drivers
Table 12. Nuclear Medicine Market Challenges
Table 13. Nuclear Medicine Market Restraints
Table 14. Global Nuclear Medicine Revenue by Players (US$ Million), 2021–2026
Table 15. Global Nuclear Medicine Market Share by Players (2021–2026)
Table 16. Global Top Nuclear Medicine Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nuclear Medicine Revenue, 2025
Table 17. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 20. Global Key Players of Nuclear Medicine, Products and Applications
Table 21. Global Key Players of Nuclear Medicine, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Nuclear Medicine Market Size by Type (US$ Million), 2021–2026
Table 24. Global Nuclear Medicine Revenue Market Share by Type (2021–2026)
Table 25. Global Nuclear Medicine Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Nuclear Medicine Revenue Market Share by Type (2027–2032)
Table 27. Global Nuclear Medicine Market Size by Application (US$ Million), 2021–2026
Table 28. Global Nuclear Medicine Revenue Market Share by Application (2021–2026)
Table 29. Global Nuclear Medicine Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Nuclear Medicine Revenue Market Share by Application (2027–2032)
Table 31. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Nuclear Medicine Market Size by Country (US$ Million), 2021–2026
Table 33. North America Nuclear Medicine Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Nuclear Medicine Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Nuclear Medicine Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Nuclear Medicine Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Nuclear Medicine Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Nuclear Medicine Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Nuclear Medicine Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Nuclear Medicine Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Nuclear Medicine Market Size by Country (US$ Million), 2027–2032
Table 46. Cardinal Health Company Details
Table 47. Cardinal Health Business Overview
Table 48. Cardinal Health Nuclear Medicine Product
Table 49. Cardinal Health Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 50. Cardinal Health Recent Development
Table 51. GE Healthcare Company Details
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclear Medicine Product
Table 54. GE Healthcare Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 55. GE Healthcare Recent Development
Table 56. Jubilant Pharma Company Details
Table 57. Jubilant Pharma Business Overview
Table 58. Jubilant Pharma Nuclear Medicine Product
Table 59. Jubilant Pharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 60. Jubilant Pharma Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Nuclear Medicine Product
Table 64. Novartis Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 65. Novartis Recent Development
Table 66. Curium Pharma Company Details
Table 67. Curium Pharma Business Overview
Table 68. Curium Pharma Nuclear Medicine Product
Table 69. Curium Pharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 70. Curium Pharma Recent Development
Table 71. SIEMENS Company Details
Table 72. SIEMENS Business Overview
Table 73. SIEMENS Nuclear Medicine Product
Table 74. SIEMENS Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 75. SIEMENS Recent Development
Table 76. Lantheus Company Details
Table 77. Lantheus Business Overview
Table 78. Lantheus Nuclear Medicine Product
Table 79. Lantheus Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 80. Lantheus Recent Development
Table 81. Bracco Imaging Company Details
Table 82. Bracco Imaging Business Overview
Table 83. Bracco Imaging Nuclear Medicine Product
Table 84. Bracco Imaging Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 85. Bracco Imaging Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Nuclear Medicine Product
Table 89. Bayer Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 90. Bayer Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 95. Eli Lilly Recent Development
Table 96. Aurobindo Pharma Company Details
Table 97. Aurobindo Pharma Business Overview
Table 98. Aurobindo Pharma Nuclear Medicine Product
Table 99. Aurobindo Pharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 100. Aurobindo Pharma Recent Development
Table 101. Mundipharma Company Details
Table 102. Mundipharma Business Overview
Table 103. Mundipharma Nuclear Medicine Product
Table 104. Mundipharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 105. Mundipharma Recent Development
Table 106. China Isotope & Radiation Company Details
Table 107. China Isotope & Radiation Business Overview
Table 108. China Isotope & Radiation Nuclear Medicine Product
Table 109. China Isotope & Radiation Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 110. China Isotope & Radiation Recent Development
Table 111. Yantai Dongcheng Company Details
Table 112. Yantai Dongcheng Business Overview
Table 113. Yantai Dongcheng Nuclear Medicine Product
Table 114. Yantai Dongcheng Revenue in Nuclear Medicine Business (US$ Million), 2021–2026
Table 115. Yantai Dongcheng Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Nuclear Medicine Picture
Figure 2. Global Nuclear Medicine Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Nuclear Medicine Market Share by Type: 2025 vs 2032
Figure 4. Diagnostic Nuclear Medicine Features
Figure 5. Therapeutic Nuclear Medicine Features
Figure 6. Global Nuclear Medicine Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Nuclear Medicine Market Share by Application: 2025 vs 2032
Figure 8. Oncology Case Studies
Figure 9. Thyroid Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Others Case Studies
Figure 12. Nuclear Medicine Report Years Considered
Figure 13. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Nuclear Medicine Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Nuclear Medicine Market Share by Region: 2025 vs 2032
Figure 16. Global Nuclear Medicine Market Share by Players in 2025
Figure 17. Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2025
Figure 19. North America Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Nuclear Medicine Market Share by Country (2021–2032)
Figure 21. United States Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Nuclear Medicine Market Share by Country (2021–2032)
Figure 25. Germany Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Nuclear Medicine Market Share by Region (2021–2032)
Figure 33. China Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Nuclear Medicine Market Share by Country (2021–2032)
Figure 41. Mexico Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Nuclear Medicine Market Share by Country (2021–2032)
Figure 45. Israel Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Cardinal Health Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 49. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 50. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 51. Novartis Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 52. Curium Pharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 53. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 54. Lantheus Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 55. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 56. Bayer Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 57. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 58. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 59. Mundipharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 60. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 61. Yantai Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
